<?xml version='1.0' encoding='UTF-8'?>
<PolymerNanocomposite><PDB_ID>4DSY</PDB_ID><DATA_SOURCE><Citation><CitationType>research article</CitationType><Publication>Chemical Biology &amp; Drug Design</Publication><Title>Identification of Purple Acid Phosphatase Inhibitors by Fragment-Based Screening: Promising New Leads for Osteoporosis Therapeutics</Title><Author>Feder, Daniel</Author><Author>Hussein, Waleed M.</Author><Author>Clayton, Daniel J.</Author><Author>Kan, Meng-Wei</Author><Author>Schenk, Gerhard</Author><Author>McGeary, Ross P.</Author><Author>Guddat, Luke W.</Author><PublicationYear>2012</PublicationYear><DOI>10.1111/cbdd.12001</DOI><Volume>80</Volume><Issue>5</Issue></Citation></DATA_SOURCE><MATERIALS><Matrix><MatrixComponent><ChemicalName>Fe(3+)-Zn(2+) purple acid phosphatase</ChemicalName><MacroMoleculeClass>HYDROLASE/HYDROLASE INHIBITOR</MacroMoleculeClass><MacroMoleculeType>Protein</MacroMoleculeType><ManufacturerOrSourceName>Phaseolus vulgaris</ManufacturerOrSourceName><MolecularWeight><value>208097.33</value></MolecularWeight></MatrixComponent></Matrix></MATERIALS><CHARACTERIZATION><XRay_Diffraction_and_Scattering><Equipment>AUSTRALIAN SYNCHROTRON BEAMLINE MX2 ADSC QUANTUM 315r</Equipment><Description>Resolution: 2.3</Description></XRay_Diffraction_and_Scattering></CHARACTERIZATION><PROPERTIES><Biological><Sequence>KNRDMPLDSDVFRVPPGYNAPQQVHITQGDLVGRAMIISWVTMDEPGSSAVRYWSEKNGRKRIAKGKMSTYRFFNYSSGFIHHTTIRKLKYNTKYYYEVGLRNTTRRFSFITPPQTGLDVPYTFGLIGDLGQSFDSNTTLSHYELSPKKGQTVLFVGDLSYADRYPNHDNVRWDTWGRFTERSVAYQPWIWTAGNHEIEFAPEINETEPFKPFSYRYHVPYEASQSTSPFWYSIKRASAHIIVLSSYSAYGRGTPQYTWLKKELRKVKRSETPWLIVLMHSPLYNSYNHHFMEGEAMRTKFEAWFVKYKVDVVFAGHVHAYERSERVSNIAYKITNGLCTPVKDQSAPVYITIGDAGNYGVIDSNMIQPQPEYSAFREASFGHGMFDIKNRTHAHFSWNRNQDGVAVEADSVWFFNRHWYPVDDST</Sequence><SpaceGroup>P 31 2 1</SpaceGroup></Biological></PROPERTIES></PolymerNanocomposite>